VASCULITIS SYNDROMES RAVE about rituximab in ANCA vasculitis?

被引：1

作者：

Tarzi, Ruth ^{[1
]}

Pusey, Charles ^{[1
]}

机构：

[1] Hammersmith Hosp, Dept Med, Renal & Vasc Inflammat Sect, London W12 0NN, England

来源：

NATURE REVIEWS NEPHROLOGY | 2013年 / 9卷 / 11期

关键词：

ANTIBODY-ASSOCIATED VASCULITIS; WEGENERS-GRANULOMATOSIS; CYCLOPHOSPHAMIDE; REMISSION; INDUCTION; EFFICACY; THERAPY;

D O I：

10.1038/nrneph.2013.204

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Follow-up data from the RAVE trial have shown that rituximab is as effective as immunosuppression with cyclophosphamide followed by azathioprine in antineutrophil cytoplasmic antibody (ANCA) associated vasculitis. Rituximab is likely to become the standard of care for many patients with ANCA disease. However, an individualized approach is needed to identify those who require more-intense or prolonged therapy.

引用

页码：628 / 629

页数：2

共 50 条

[41] Is it time to say goodbye to weekly rituximab in ANCA vasculitis?
Pinto, Benzeeta
Dhooria, Aadhaar
CLINICAL RHEUMATOLOGY, 2020, 39 (10) : 3153 - 3154
[42] Renal disease in ANCA-associated vasculitis
Vanhille, Philippe
Vrigneaud, Laurence
Quemeneur, Thomas
PRESSE MEDICALE, 2012, 41 (03): : 247 - 253
[43] Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial
Smith, Rona M.
Jones, Rachel B.
Specks, Ulrich
Bond, Simon
Nodale, Marianna
Al-jayyousi, Reem
Andrews, Jacqueline
Bruchfeld, Annette
Camilleri, Brian
Carette, Simon
Cheung, Chee Kay
Derebail, Vimal
Doulton, Tim
Ferraro, Alastair
Forbess, Lindsy
Fujimoto, Shouichi
Furuta, Shunsuke
Gewurz-Singer, Ora
Harper, Lorraine
Ito-Ihara, Toshiko
Khalidi, Nader
Klocke, Rainer
Koening, Curry
Komagata, Yoshinori
Langford, Carol
Lanyon, Peter
Luqmani, Raashid
McAlear, Carol
Moreland, Larry W.
Mynard, Kim
Nachman, Patrick
Pagnoux, Christian
Peh, Chen Au
Pusey, Charles
Ranganathan, Dwarakanathan
Rhee, Rennie L.
Spiera, Robert
Sreih, Antoine G.
Tesar, Vladamir
Walters, Giles
Wroe, Caroline
Jayne, David
Merkel, Peter A.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (07) : 937 - 944
[44] Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal Involvement
Geetha, Duvuru
Specks, Ulrich
Stone, John H.
Merkel, Peter A.
Seo, Philip
Spiera, Robert
Langford, Carol A.
Hoffman, Gary S.
Kallenberg, Cees G. M.
St Clair, E. William
Fessler, Barri J.
Ding, Linna
Tchao, Nadia K.
Ikle, David
Jepson, Brett
Brunetta, Paul
Fervenza, Fernando C.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (04): : 976 - 985
[45] Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients
Wendt, M.
Gunnarsson, I.
Bratt, J.
Bruchfeld, A.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2012, 41 (02) : 116 - 119
[46] Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis
van Daalen, Emma E.
Rizzo, Raffaella
Kronbichler, Andreas
Wolterbeek, Ron
Bruijn, Jan A.
Jayne, David R.
Bajema, Ingeborg M.
Rahmattulla, Chinar
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (06) : 1064 - 1069
[47] Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course
Tariq, Anam
Akenroye, Ayobami
Azar, Antoine
Seo, Philip
Geetha, Duvuru
EUROPEAN JOURNAL OF RHEUMATOLOGY, 2022, 9 (02) : 93 - 99
[48] ANCA associated vasculitis
Hunter, Robert W.
Welsh, Nicola
Farrah, Tariq E.
Gallacher, Peter J.
Dhaun, Neeraj
BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
[49] ANCA associated vasculitis
Salvador, Fernando
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 74 : 18 - 28
[50] Infections in ANCA-associated vasculitis and lupus nephritis treated with rituximab
Temiz, Sultan Gozde
Barutcu Atas, Dilek
Alibaz Oner, Fatma
Velioglu, Arzu
Hakki Arikan, Izzet
Tuglular, Zubeyde Serhan
Direskeneli, Rafi Haner
Asicioglu, Ebru
MARMARA MEDICAL JOURNAL, 2024, 37 (03): : 268 - 273

← 1 2 3 4 5 →